DOSSIER · 13F-HR · Q2 2026

DIADEMA PARTNERS LP

$791M in tracked AUM across 149 positions as of Q2 2026.

DP
CIK 0002026172 · last filed Jun 30, 2026
Total AUM
$791M
as of Q2 2026
Holdings
149
positions
Whale Score
54
54
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

DIADEMA PARTNERS LP filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
ABVX
ABIVAX SA
$102M765K12.9%
02
VKTX
VIKING THERAPEUTICS INC
$79M2.0M9.9%
03
BMY
BRISTOL-MYERS SQUIBB CO
$54M931K6.8%
04
UTHR
UNITED THERAPEUTICS CORP DEL
$29M53K3.6%
05
RVMD
REVOLUTION MEDICINES INC
$26M139K3.3%
06
N90064101
UNIQURE NV
$25M534K3.1%
07
NVS
NOVARTIS AG
$24M150K3.0%
08
KOD
KODIAK SCIENCES INC
$22M562K2.8%
09
CAPR
CAPRICOR THERAPEUTICS INC
$21M864K2.6%
10
COGT
COGENT BIOSCIENCES INC
$19M494K2.4%

Filing history

2026Q2Jun 30
$791M 34.6%
149 positionsView →
2026Q1Mar 31
$588M 1.2%
144 positionsView →
2025Q4Dec 31
$581M 98.6%
145 positionsView →
2025Q3Sep 30
$292M 10.9%
88 positionsView →
2025Q2Jun 30
$328M 86.1%
96 positionsLocked
2025Q1Mar 31
$176M 24.3%
69 positionsLocked
2024Q4Dec 31
$233M
107 positionsLocked